Actively Recruiting
Effect of Antioxydant-enriched Media on Blastocyst Euploidy Rates.
Led by ART Fertility Clinics LLC · Updated on 2025-02-21
500
Participants Needed
1
Research Sites
99 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
One of the most sensible factors in IVF culture conditions is the susceptibility of gametes and embryos to an induced increase in reactive oxidative species (ROS) caused by the artificial environment. This study aims to evaluate the impact of using antioxidant-supplemented media during culture to evaluate embryo ploidy rates in a prospective randomized trial using sibling oocytes.
CONDITIONS
Official Title
Effect of Antioxydant-enriched Media on Blastocyst Euploidy Rates.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients undergoing assisted reproductive technology cycles when ICSI is indicated
- Patients undergoing IVF with enough oocytes for ICSI randomization (IVF oocytes not used for study)
- Maternal age between 18 and 43 years
- PGT-A cycles with trophectoderm biopsies on day 5, 6, or 7
- Expected more than 6 cumulus-oocyte complexes (COCs) for ICSI
- Body mass index (BMI) less than 35
- Use of fresh or frozen ejaculated sperm
You will not qualify if you...
- PGT-M cycles
- Use of fresh or frozen testicular sperm
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
ART Fertility Clinics LLC
Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates, 60202
Actively Recruiting
Research Team
D
Daniela Nogueira
CONTACT
J
Jonalyn DV Edades
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here